As a blockchain analyst who’s seen every hype cycle and crash, I’m watching with skepticism—and intrigue—how Opyl Limited, an ASX-listed AI biotech firm, just bought 2 BTC via DigitalX ETF. This isn’t just crypto speculation; it’s a high-stakes bet on financial resilience. With a $130K loan secured against its Bitcoin holdings, this move blurs the line between tech innovation and corporate lifeline. Let’s unpack why even struggling startups are turning to Bitcoin as their new balance sheet anchor.